{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:28:50Z","timestamp":1778624930646,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSF-223-2018-10020I"],"award-info":[{"award-number":["HHSF-223-2018-10020I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75F40123F19005"],"award-info":[{"award-number":["75F40123F19005"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127069","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:35:16Z","timestamp":1744133716000},"page":"127069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Safety monitoring of health outcomes following influenza vaccination during the 2023\u20132024 season among U.S. Medicare beneficiaries aged 65\u00a0years and older"],"prefix":"10.1016","volume":"53","author":[{"given":"Patricia C.","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyanada","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin","family":"Anguzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derick","family":"Ambarsoomzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tainya C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoganand","family":"Chillarige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Forshee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127069_bb0005","unstructured":"Centers for Disease Control and Prevention. Key Facts About Seasonal Flu Vaccine [Available from: https:\/\/www.cdc.gov\/flu\/prevent\/keyfacts.htm."},{"key":"10.1016\/j.vaccine.2025.127069_bb0010","unstructured":"U.S. Food and Drug Administration. Influenza Vaccine for the 2023-2024 Season [Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/lot-release\/influenza-vaccine-2023-2024-season."},{"key":"10.1016\/j.vaccine.2025.127069_bb0015","unstructured":"U.S. Food and Drug Administration. Influenza Vaccine for the 2022-2023 Season [Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/lot-release\/influenza-vaccine-2022-2023-season."},{"key":"10.1016\/j.vaccine.2025.127069_bb0020","unstructured":"Centers for Disease Control and Prevention. IIS Data Code Sets [Available from: https:\/\/www.cdc.gov\/vaccines\/programs\/iis\/code-sets.html."},{"key":"10.1016\/j.vaccine.2025.127069_bb0025","unstructured":"Centers for Disease Control and Prevention. Seasonal Flu Vaccines [Available from: https:\/\/www.cdc.gov\/flu\/prevent\/flushot.htm."},{"issue":"9","key":"10.1016\/j.vaccine.2025.127069_bb0030","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1080\/21645515.2016.1182270","article-title":"Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: a phase III, double-blind, multicenter, randomized, non-inferiority study","volume":"12","author":"Bart","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127069_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciz202","article-title":"Safety of inactivated influenza vaccine in cancer patients receiving immune checkpoint inhibitors","volume":"70","author":"Chong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127069_bb0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/v13061109","article-title":"The nature of immune responses to influenza vaccination in high-risk populations","volume":"13","author":"Wiggins","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127069_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JAC.0000000000000107","article-title":"Characteristics of Medicare advantage and fee-for-service beneficiaries upon enrollment in Medicare at age 65","volume":"39","author":"Miller","year":"2016","journal-title":"J Ambul Care Manage"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127069_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MLR.0000000000001680","article-title":"Trends in characteristics of adults enrolled in traditional fee-for-service Medicare and Medicare advantage, 2011\u20132019","volume":"60","author":"Weeks","year":"2022","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127069_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2025.127069_bb0060","unstructured":"Biologics Effectiveness and Safety (BEST) Initiative. Evaluation of Nine Safety Outcomes following 2023-2024 Influenza Vaccination in Persons 6 Months and Older 2024 [Available from: https:\/\/bestinitiative.org\/wp-content\/uploads\/2024\/02\/BEST_Influenza_Vaccine_Protocol_2023-2024.pdf."},{"key":"10.1016\/j.vaccine.2025.127069_bb0065","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127069_bb0070","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2024.1059","article-title":"Stroke risk after COVID-19 bivalent vaccination among US older adults","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127069_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23926","article-title":"Stroke after influenza vaccines in older adults in the US, 2016 to 2019","volume":"7","author":"Lu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"494","key":"10.1016\/j.vaccine.2025.127069_bb0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1198\/jasa.2011.ap10108","article-title":"Self-controlled case series analysis with event-dependent observation periods","volume":"106","author":"Farrington","year":"2011","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2025.127069_bb0085","unstructured":"United States (U.S.) Department of Health and Human Services (DHHS). 45 CFR 46 - Common Rule - Protections for Research Subjects 2021 [Available from: https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/index.html."},{"key":"10.1016\/j.vaccine.2025.127069_bb0090","unstructured":"Centers for Medicare & Medicaid Services. Data Snapshot: Annual Influenza Vaccination Disparities in Medicare Beneficiaries 2024 [Available from: https:\/\/www.cms.gov\/files\/document\/data-snapshot-annual-influenza-vaccination.pdf."},{"key":"10.1016\/j.vaccine.2025.127069_bb0095","unstructured":"Centers for Medicare & Medicaid Services. Medicare Monthly Enrollment. 2024."},{"issue":"41","key":"10.1016\/j.vaccine.2025.127069_bb0100","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1016\/j.vaccine.2015.08.013","article-title":"Influenza vaccination and risk of stroke: self-controlled case-series study","volume":"33","author":"Asghar","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127069_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12872-020-01836-z","article-title":"Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study","volume":"21","author":"Sen","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.vaccine.2025.127069_bb0110","doi-asserted-by":"crossref","DOI":"10.2196\/53807","article-title":"Ischemic stroke after bivalent COVID-19 vaccination: self-controlled case series study","volume":"10","author":"Xu","year":"2024","journal-title":"JMIR Public Health Surveill"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127069_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1747493018816430","article-title":"How do neurologists diagnose transient ischemic attack: a systematic review","volume":"14","author":"Fitzpatrick","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/j.vaccine.2025.127069_bb0120","unstructured":"Centers for Disease and Control and Prevention. CDC Seasonal Flu Vaccine Effectiveness Studies. 2024."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127069_bb0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12889-021-10916-4","article-title":"Risk of stroke and myocardial infarction after influenza-like illness in New York state","volume":"21","author":"Kulick","year":"2021","journal-title":"BMC Public Health"},{"issue":"28","key":"10.1016\/j.vaccine.2025.127069_bb0130","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1016\/j.vaccine.2021.05.011","article-title":"Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research","volume":"39","author":"Ferdinands","year":"2021","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2025.127069_bb0135","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.vaccine.2018.07.028","article-title":"Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012\u20132015","volume":"36","author":"Thompson","year":"2018","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2025.127069_bb0140","article-title":"Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010\/11 to 2015\/16","volume":"23","author":"Godoy","year":"2018","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127069_bb0145","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:58:39Z","timestamp":1778623119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"alternative-id":["S0264410X25003664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127069","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.03.25319959","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety monitoring of health outcomes following influenza vaccination during the 2023\u20132024 season among U.S. Medicare beneficiaries aged 65\u00a0years and older","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127069"}}